Age of onset of amyotrophic lateral sclerosis is modulated by a locus on 1p34.1.
Ahmeti Kreshnik B,Ajroud-Driss Senda,Al-Chalabi Ammar,Andersen Peter M,Armstrong Jennifer,Birve Anne,Blauw Hylke M,Brown Robert H,Bruijn Lucie,Chen Wenjie,Chio Adriano,Comeau Mary C,Cronin Simon,Diekstra Frank P,Soraya Gkazi Athina,Glass Jonathan D,Grab Josh D,Groen Ewout J,Haines Jonathan L,Hardiman Orla,Heller Scott,Huang Jie,Hung Wu-Yen,null null,Jaworski James M,Jones Ashley,Khan Humaira,Landers John E,Langefeld Carl D,Leigh P Nigel,Marion Miranda C,McLaughlin Russell L,Meininger Vincent,Melki Judith,Miller Jack W,Mora Gabriele,Pericak-Vance Margaret A,Rampersaud Evadnie,Robberecht Wim,Russell Laurie P,Salachas Francois,Saris Christiaan G,Shatunov Aleksey,Shaw Christopher E,Siddique Nailah,Siddique Teepu,Smith Bradley N,Sufit Robert,Topp Simon,Traynor Bryan J,Vance Caroline,van Damme Philip,van den Berg Leonard H,van Es Michael A,van Vught Paul W,Veldink Jan H,Yang Yi,Zheng J G,null null
DOI: https://doi.org/10.1016/j.neurobiolaging.2012.07.017
IF: 5.133
2013-01-01
Neurobiology of Aging
Abstract:Amyotrophic lateral sclerosis (ALS) is the third most common adult-onset neurodegenerative disease. Individuals with ALS rapidly progress to paralysis and die from respiratory failure within 3 to 5 years after symptom onset. Epidemiological factors explain only a modest amount of the risk for ALS. However, there is growing evidence of a strong genetic component to both familial and sporadic ALS risk. The International Consortium on Amyotrophic Lateral Sclerosis Genetics was established to bring together existing genome-wide association cohorts and identify sporadic ALS susceptibility and age at symptom onset loci. Here, we report the results of a meta-analysis of the International Consortium on Amyotrophic Lateral Sclerosis Genetics genome-wide association samples, consisting of 4243 ALS cases and 5112 controls from 13 European ancestry cohorts from across the United States and Europe. Eight genomic regions provided evidence of association with ALS, including 9p21.2 (rs3849942, odds ratio [OR] = 1.21; p = 4.41 x 10(-7)), 17p11.2 (rs7477, OR = 1.30; p = 2.89 x 10(-7)), and 19p13 (rs12608932, OR = 1.37, p = 1.29 x 10(-7)). Six genomic regions were associated with age at onset of ALS. The strongest evidence for an age of onset locus was observed at 1p34.1, with comparable evidence at rs3011225 (R-partial(2) = 0.0061; p = 6.59 x 10(-8)) and rs803675 (R-partial(2) = 0.0060; p = 6.96 x 10(-8)). These associations were consistent across all 13 cohorts. For rs3011225, individuals with at least 1 copy of the minor allele had an earlier average age of onset of over 2 years. Identifying the underlying pathways influencing susceptibility to and age at onset of ALS may provide insight into the pathogenic mechanisms and motivate new pharmacologic targets for this fatal neurodegenerative disease. (C) 2013 Elsevier Inc. All rights reserved.